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Abstract
Objective: To determine the predictive value of the ‘‘Timed Up & Go’’ (TUG), a validated assessment tool, on a prospective
cohort study and to compare these findings to the ASA classification, an instrument commonly used for quantifying
patients’ physical status and anesthetic risk.
Background: In the onco-geriatric surgical population it is important to identify patients at increased risk of adverse post-
operative outcome to minimize the risk of over- and under-treatment and improve outcome in this population.
Methods: 280 patients $70 years undergoing elective surgery for solid tumors were prospectively recruited. Primary
endpoint was 30-day morbidity. Pre-operatively TUG was administered and ASA-classification was registered. Data were
analyzed using multivariable logistic regression analyses to estimate odds ratios (OR) and 95% confidence intervals (95%-CI).
Absolute risks and area under the receiver operating characteristic curves (AUC’s) were calculated.
Results: 180 (64.3%) patients (median age: 76) underwent major surgery. 55 (20.1%) patients experienced major
complications. 50.0% of patients with high TUG and 25.6% of patients with ASA$3 experienced major complications
(absolute risks). TUG and ASA were independent predictors of the occurrence of major complications (TUG:OR 3.43; 95%-
CI = 1.14–10.35. ASA1 vs. 2:OR 5.91; 95%-CI = 0.93–37.77. ASA1 vs. 3&4:OR 12.77; 95%-CI = 1.84–88.74). AUCTUG was 0.64
(95%-CI = 0.55–0.73, p = 0.001) and AUCASA was 0.59 (95%-CI = 0.51–0.67, p = 0.04).
Conclusions: Twice as many onco-geriatric patients at risk of post-operative complications, who might benefit from pre-
operative interventions, are identified using TUG than when using ASA.
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Introduction
With the ageing of our society, the onco-geriatric surgical
population is expected to increase. Currently 40% of all
malignancies occur in patients over 70 years of age and the
majority of patients undergoing surgery for a solid tumor are
elderly[1–3]. Roughly 40% of this onco-geriatric surgical popu-
lation can be considered to be frail [4,5], which is defined as ‘a loss
of resources in several domains of functioning’ resulting in
increased vulnerability to stressors [6].
Frail onco-geriatric patients are at an increased risk of adverse
outcome due to complications [7]. These patients need to be
identified pre-operatively to allow the effective implementation of
preventive measures, to minimize the risk of over- and under-
treatment and improve outcome in this population. The compre-
hensive geriatric assessment (CGA) has been introduced to identify
frailty in geriatric oncology [8,9]. Unfortunately, CGA is time
consuming and hence difficult to utilize in a busy clinical surgical
practice. To easily identify which patients are at risk of post-
operative complications and might benefit from further assessment
and pre-operative interventions [10,11], time saving screening
tools need to be investigated.
The American Society of Anesthesiology classification (ASA) is a
well-known classification that quantifies the pre-operative physical
status and gives an estimation of a patient’s anesthetic risk [12].
Studies show opposing results regarding the predictive value of
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high ASA-scores for post-operative morbidity and mortality[4,13–
16]. So far, the ASA-classification has not been proven predictive
of post-operative outcome in onco-geriatric patients.
The ‘‘Timed Up and Go’’ (TUG) is a tool that has been made
available for the purpose of identifying frail elderly by quantifying
functional mobility [17]. It is an easy to administer measure of
functional status. The TUG has extensively been studied in
community dwelling elderly[18–22] and it was found to predict
the risk of early death in onco-geriatric patients receiving
chemotherapy [23]. The TUG was also investigated in cohorts
of surgical patients. The TUG predicts long-term functional
outcome in patients undergoing hip surgery [24,25]. In patients
undergoing major cardiovascular or abdominal surgery, the TUG
successfully predicted discharge institutionalization and post-
operative delirium [26,27]. Data on the predictive value of the
TUG in the onco-geriatric surgical population are lacking.
Our aim was to determine the predictive value of the TUG in a
prospective cohort study and to compare this to the ASA-




Approval from the National Research Ethics Service Commit-
tee North West - Greater Manchester Central and the Medical
Ethical Committee from Leiden University Medical Center was
obtained and all included patients gave written informed consent.
There was no financial incentive to the contributing centers for
entering patients into the present study and no funding was
acquired. PREOP is registered at the Dutch Trial register (Trial
ID: NTR1567).
Design
A multicenter prospective cohort study was designed to
investigate Pre-operative Risk Estimation for Onco-geriatric
Patients (PREOP). The PREOP-study is an international study
conducted to analyze several screening tools with regard to short
term post-operative outcome. Recruitment took place in 6
different countries at 11 medical centers between September
2008 and January 2012. To reduce the possibility of selection bias
and the influence of intercenter variability, medical centers that
included less than 10 patients were excluded from analysis.
Centers participated actively during different periods of time,
depending on the availability of research staff, explaining the
relatively small number of included patients considering the long
inclusion period.
Patients
A cohort of cancer patients aged $70 who were candidate for
elective surgery under general anesthesia, were invited to take part
by the local coordinator. Patients requiring emergency surgical
management (within 24 hours) were excluded from this study. This
international study sample comprised a series of 319 patients.
Medical centers that included less than 10 patients were excluded
from analysis, which resulted in the analysis of 280 patients
(table 1).
Endpoints
The primary endpoint was morbidity during the first 30 days
after surgery. Morbidity was registered using the Clavien-Dindo
classification, a scale ranking severity of complications from ‘any
deviation from the normal post-operative course without the need
for pharmacological treatment or surgical, endoscopic and
radiological interventions’ (grade one) to ‘death of a patient’
(grade five) [28]. Morbidity was dichotomized into minor (Clavien-
Dindo grade one and two) and major complications (Clavien-
Dindo grade three to five). Subsequently, a dichotomous variable
was created for morbidity during the first 30 days after surgery:
‘‘no/minor’’ versus ‘‘major’’ complications. Secondary endpoints
were 30-day mortality, length of hospital stay, amount of days
spent in the Intensive Care Unit (ICU) and the number of
additional specialists involved in patient care. The secondary
endpoints were dichotomized and cut off points were fixed at .7
days for length of stay after surgery, which was considered
prolonged length of stay (LOS), .1 day admission at the ICU and
.3 additional specialists involved in patient care.
Pre- and Peri-operative Data
Within two weeks prior to the surgical procedure, the TUG was
administered as part of a larger test battery. TUG measures the
time a person needs to get up out of a chair, walk three meters and
return to the chair [17]. This is measured in seconds with a
handheld stopwatch. Patients performed the TUG two times and
for each patient, the mean of the two time measurements was
calculated. Based on literature and the distribution of the mean
values in the current study population, a score of less than or equal
to 20 seconds on the TUG was considered a normal score [26].
The ASA-classification, ranging from ‘a normal healthy patient’
(ASA1) to ‘moribund, i.e. not expected to survive 24 h with or
without surgery’ (ASA5), was determined by an anesthesiologist.
The patients with score ASA 3 and ASA4 were combined for
analysis.
Pre-operative information regarding living situation, pre-oper-
ative hemoglobin level, nutritional status and comorbidity was
recorded.
Nutritional status was defined according to the following
definitions [29]:
Normal nutritional status.
Mildly impaired nutritional status:.5% weight loss in 3 months
or food intake less than 50–75% of their normal requirements in
the past week.
Moderately impaired nutritional status: .5% weight loss in 2
months or BMI 18.5–20.5+ poor overall condition or food intake
25–60% of their normal requirements in the past week.
Severely impaired nutritional status: .5% weight loss in 1
month (.15% in 3 months) or BMI ,18.5+ poor overall
condition or food intake 0–25% of their normal requirements in
the past week.
Peri-operative data contained type of surgery (dichotomized
into minor and major surgery), duration of anesthesia and blood
loss during surgery.
At every participating center data were collected by a research
nurse.
Statistical Analysis
In a univariable logistic regression the odds ratios (OR) and
95% confidence intervals (95%-CIs) were assessed for the presence
of a major complication for each of the baseline characteristics
including the TUG, ASA-score and TUG and ASA-score
combined (TUG+ASA). When combining TUG and ASA-score,
we divided this variable into three categories: 1) normal TUG and
ASA1 or ASA2; 2) high TUG or ASA$3; 3) high TUG and
ASA$3. We focused on the results on high TUG and ASA$3
compared to both normal values. All ORs and 95%-CIs were
adjusted for medical center, as there were large differences
between the participating centers regarding the number of patients
included and the type of performed surgeries. To further adjust for
Preoperative Screening in Onco-Geriatric Patients
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contributing factors, all baseline characteristics were added to the
center-adjusted model, including TUG or ASA or TUG+ASA. A
variable was selected for multivariable analysis when a significant
OR with a minimal change of OR of 10% was observed in
comparison with the center-adjusted univariable model containing
TUG, ASA or TUG+ASA. The same procedure was repeated for
the secondary endpoints. Sensitivity and specificity of the TUG,
ASA and TUG+ASA were calculated for the primary outcome
measure. To make an accurate estimation of a patient’s risk for a
certain outcome, absolute risks were calculated [30]. The area
under the receiver operating characteristic curves (AUCs) together
with 95%-CIs were calculated for the TUG, ASA and TUG+ASA,
if applicable. P-values ,0.05 were considered statistically signif-




The median age of this cohort was 76 years (Range: 70–96) and
65% of patients were female(table 2). The majority of surgical
procedures were laparotomies (n = 171; 61.1%) and breast cancer
surgeries (n = 76; 27.1%) (table 2). Types of malignancies treated
by means of a laparotomy were colorectal cancer (n = 95), gastric
cancer (n = 24), pancreatic cancer (n = 15), cholangio-, gallblad-
der- and papilla of Vater carcinoma (n = 8), ovarian cancer (n = 6),
liver metastases of colon cancer (n = 6), and other solid tumors
(n = 16). One patient underwent a laparotomy for both colon and
renal cell carcinoma. The majority of patients (64.3%) underwent
major surgery. The median TUG in our sample was 11.2 seconds
(Q1–Q3 8.2–15.8). A total of 237 patients (84.9%) completed the
TUG within 20 seconds. The majority of patients were classified as
ASA2 (n = 131; 47.3%) and ASA3 (n= 113; 40.8%). A total of 142
patients (51.4%) had both a normal TUG and ASA,3 (table 2).
Primary Outcome Measure
Complications occurred in 135 patients (48.2%) and of these
patients, 55 patients developed major complications (table 3).
Compared to women (12.8%), men (33.3%) were at higher risk of
developing major complications post-operatively (OR 3.47; 95%-
CI= 1.71–7.05; p = 0.001) (table 4), even when corrected for
minor or major surgery (OR 2.34; 95%-CI= 1.12–4.89; p = 0.02).
The absolute risk for patients with high TUG to develop major
complications was 50%, in contrast for patients with normal TUG
which was 14.7% (table 4&5). Almost all patients that developed
major complications and had a normal TUG underwent major
surgery (n = 31; 91.2%). After adjustment for nutritional status and
minor or major surgery, patients with a high TUG had a 3.43
times higher risk of developing major complications within 30 days
post-operatively as compared to patients with normal TUG (95%-
CI= 1.14–10.35; p= 0.03) (table 5). Sensitivity of a high TUG was
38.2% and specificity was 90.4%. The AUC was 0.64 (95%-
CI= 0.55–0.73; p= 0.001).
A total of 25.6% of patients classified as ASA3 or ASA4
developed major complications (table 4&5). From the patients
classified as ASA1 or 2 who did develop major complications post-
operatively, 22 (91.7%) underwent major surgery. Patients
classified as ASA2 had a 5.91 times higher risk of experiencing
major complications compared to patients labeled as ASA1 (95%-
CI= 0.93–37.77; p = 0.06), when adjusted for nutritional status
and minor or major surgery. Patients classified as ASA3 or ASA4
had a 12.77 times higher risk of major complications compared to
patients classified as ASA1 (95%-CI= 1.84–88.74; p = 0.01)
(table 5). Sensitivity of ASA$3 was 55.6% and specificity was
59.9%. The AUC was 0.59 (95%-CI= 0.51–0.67, p = 0.04).
A total of 46.2% (n= 12) of patients with both a high TUG and
ASA$3 developed major complications, compared to 10.8%
(n= 15) of patients with a normal TUG and ASA,3 (p,0.001)
(table 4&5). Patients with both high TUG and ASA$3 had a 5.22
times higher risk of developing major complications compared to
patients with a normal TUG and ASA,3 (95%-CI= 1.24–21.98;
p = 0.02), when adjusted for nutritional status and minor or major
surgery (table 5). Sensitivity was 44.4% and specificity was 89.9%.
The AUC was 0.67 (95%-CI= 0.59–0.75; p,0.001).
Secondary Outcome Measures
30-day mortality. Ten patients died post-operatively (30-day
mortality rate: 3.6%) (table 3), all these patients developed major
complications prior to death. Four patients died of a pulmonary
embolism, three patients died of sepsis, two died of advanced
neoplastic disease and one passed away after myocardial
infarction. In a univariable logistic regression analysis the TUG
and ASA were not predictive of 30-day mortality; therefore, no
multivariable logistic regression analysis was performed for
mortality.
The Chi2-test was not statistically significant for the combined
TUG and ASA variable, so no logistic regression analysis was
performed.
Length of stay. After surgery, 147 patients (52.9%) stayed
over 7 days in hospital (table 3) and from these patients, 140
(95.2%) underwent major surgery. The absolute risk for patients
with a high TUG to have a prolonged LOS was 70% (n= 28),
compared to 49.8% (n= 118) for patients with a normal TUG.
The contributing factors in the multivariable logistic regression
Table 1. Number of patients per center included in statistical analysis.
Center Number of patients
S. Orsola Malphighi Hospital, Bologna, Italy 117 (41.8%)
University Medical Center Groningen, Groningen, The Netherlands 45 (16.1%)
San Martino University Hospital, Genua, Italy 39 (13.9%)
Regional University Hospital of Patras, Patras, Greece 31 (11.1%)
The Highfield Hospital, Manchester, United Kingdom 19 (6.8%)
S. Maria Hospital, Perugia, Italy 15 (5.4%)
Clinical Center Nis, Nis, Serbia 14 (5.0%)
Total 280
doi:10.1371/journal.pone.0086863.t001
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model for the secondary endpoints were gender, minor or major
surgery and duration of anesthesia. In this multivariable logistic
regression analysis, patients with a high TUG had a 3.98 times
higher risk of prolonged LOS (95%-CI= 1.12–14.10; p= 0.03)
(table 5). The AUC was 0.55 (95%-CI= 0.48–0.62; p= 0.15).
A total of 18 patients (69.2%) with ASA1 had a prolonged LOS
and 15 of these patients (83.3%) underwent major surgery. A total
of 45.8% (n= 60) classified as ASA2 and 55.9% (n= 66) classified
as ASA3 or ASA4 had a prolonged LOS. The majority of these
patients underwent major surgery (n = 58 (96.7%) and n= 64
(97.0%) respectively). Prolonged LOS could not be predicted by
high ASA-classification in the multivariable model (ASA1 vs. 2:
OR 0.23; 95%-CI= 0.05–0.99; p = 0.05. ASA1 vs. 3&4: OR 0.37;
95%-CI= 0.08–1.68; p= 0.20) (table 5).
The Chi2-test was not statistically significant for the combined
TUG and ASA variable, so no logistic regression analysis was
performed.
Length of stay at intensive care unit. A total of 46 patients
(16.5%) required more than one day admission at the ICU
(Q3= 1) (table 3). All of these patients underwent major surgery. In
a univariable logistic regression analysis it was found that neither
TUG nor ASA were predictive of a longer stay at the ICU (TUG
p=0.08; ASA1 vs. 2 p= 0.39; ASA1 vs. 3&4 p= 0.05). Therefore,
no multivariable logistic regression analyses were performed for
these variables.
A total of 38.5% (n= 10) of patients with both a high TUG and
ASA$3 required more than one day admission at the ICU,
compared to 9.2% (n= 13) in patients with a normal TUG and
ASA,3 (p,0.001). In a multivariable logistic regression analysis,
a combined high TUG and ASA$3 was not predictive of a longer
stay at the ICU (OR 3.18; 95%-CI= 0.73–13.94; p = 0.12).
Number of specialists involved. In 45 patients (16.7%),
additional care from more than 3 specialists (Q3= 3) was required
(table 3). Compared to patients with a normal TUG, relatively
more patients with a high TUG needed care from more than 3
specialists (n = 26 (11.4%) and n= 18 (45.0%) respectively). The
multivariable logistic regression analysis showed a 5.20 times
higher chance to need care from more than 3 specialists in case of
Table 2. Characteristics of 280 patients $70 years
undergoing surgery for a solid tumor.
Variable Valuea
Age (years)b 76 (72–81)
Gender
- Female 182 (65.0%)
- Male 98 (35.0%)
Living situation
- Independent/family 274 (99.3%)
- Residential care/nursing home 2 (0.7%)
Nutritional status
- Normal 182 (67.7%)
- Mildly impaired 65 (24.2%)
- Moderately & severely impaired 22 (8.2%)
Comorbidities (n)b 3 (2–4)
Hemoglobin level
- $12g/dl 159 (61.9%)
- ,12g/dl 98 (38.1%)
Surgery
- Minor 100 (35.7%)
N Breast cancer treatment (6 lymph node) 76 (27.1%)
N Excision malignancies of soft tissue,
skin and/or lymph node
17 (6.1%)
N Thyroidectomy 4 (1.4%)
N Remaining 3 (1.1%)
- Major 180 (64.3%)
N Laparotomy 171 (61.1%)
N Laparoscopic approach of G.I. or G.U. tumors 5 (1.8%)
N Excision soft tissue sarcoma and vulvectomy 4 (1.4%)
Duration anesthesia (h)b 2.7 (1.7–4.0)
Blood loss during surgery (dl)b 1.0 (1.0–2.0)
TUG (s)b 11.2 (8.2–15.8)
TUG
- #20.0 seconds 237 (84.9%)
- .20.0 seconds 42 (15.1%)
ASA-score
- 1 26 (9.4%)
- 2 131 (47.3%)
- 3 113 (40.8%)
- 4 7 (2.5%)
TUG+ASA
- TUG#20+ ASA,3 142 (51.4%)
- TUG.20+ ASA$3 26 (9.4%)
aValid percentages were calculated when data were not available from all
patients.
bValues are median and first and third quartiles.
doi:10.1371/journal.pone.0086863.t002
Table 3. Outcomes.
Outcome measure Patients (n =280)a
Complications
- No 145 (51.8%)
- Any 135 (48.2%)
- Major 55 (20.1%)
Mortality
- No 268 (96.4%)
- Yes 10 (3.6%)
Readmission
- No 248 (91.5%)
- Yes 23 (8.5%)
Length of stay .7 days
- No 131 (47.1%)
- Yes 147 (52.9%)
Length of stay on ICU .1 day
- No 233 (83.5%)
- Yes 46 (16.5%)
.3 additional specialists involved
- No 224 (83.3%)
- Yes 45 (16.7%)
aValid percentages were calculated when data were not available from all
patients.
doi:10.1371/journal.pone.0086863.t003
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a high TUG (95%-CI= 1.78–15.16; p = 0.003) (table 5). The AUC
was 0.66 (95%-CI= 0.56–0.75; p= 0.001).
Only 2 of the patients with ASA1 (7.7%) required care from
more than 3 specialists, in patients with ASA2 this number was 10
(8.0%) and in patients classified as ASA3 or 4, this number was 31
(27.0%). Only patients classified as ASA3 or 4 were over 12 times
more likely of requiring additional care from more than 3
specialists (ASA1 vs. 2: OR 2.67; 95%-CI= 0.40–18.03; p = 0.31.
ASA1 vs. 3&4: OR 12.55; 95%-CI= 1.76–89.64; p= 0.01)
(table 5). The AUC was 0.67 (95%-CI= 0.59–0.76; p,0.001).
In 54.2% (n= 13) of patients with both a high TUG and
ASA$3, care from more than 3 specialists was required. In
patients with a normal TUG and ASA,3, this was 5.1% (n= 7).
Patients with both a high TUG and ASA$3 were 25.31 times
more likely of requiring additional care from more than 3
specialists (95%-CI= 5.51–116.27; p,0.001). The AUC was 0.75
(95%-CI= 0.67–0.83; p,0.001).
Discussion
The use of TUG and ASA as screening tools for short-term
post-operative outcome in onco-geriatric surgical patients was
investigated. Multivariable analysis showed a prognostic ability of
TUG, ASA and TUG and ASA as a combined prognostic tool
with regard to the occurrence of major complications within 30
days after surgery. Far more patients at risk of post-operative
complications, who might benefit from pre-operative interven-
tions, were identified using the TUG than when using ASA: the
absolute risk for patients with high TUG to develop major
complications was 50%, while the absolute risk for patients with
ASA3 or 4 was 25.6%. The specificity of the TUG was high
(90.4%), and the AUCTUG was better than the AUCASA. The
TUG and ASA as a combined variable showed no added value.
A considerable number of patients (n = 135; 48.2%) experienc-
ing complications within 30 days after surgery was recorded, of
Table 4. Univariable association between patient characteristics and no/minor and major complications.
Variable Major complication (n=280)a Univariable OR (95% CI)b
TUG
- #20.0 seconds 34 (14.7%) 1
- .20.0 seconds 21 (50.0%) 4.86 (1.82–13.00)
ASA-score p,0.001c
- 1 2 (8.0%) 1
- 2 22 (17.1%) 10.68 (1.79–63.70)
- 3&4 30 (25.6%) 27.77 (4.44–173.67)
TUG+ASA
- TUG#20+ ASA,3 15 (10.8%) 1
- TUG.20+ ASA$3 12 (46.2%) 8.68 (2.45–30.73)
Age (years)d 77 (73–82) 1.06 (0.99–1.13)
Gender
- Female 23 (12.8%) 1
- Male 32 (34.0%) 3.53 (1.74–7.17)
Living situation
- Independent/family 54 (20.1%) e
- Residential care/nursing home 0 (0%)
Nutritional status p,0.001c
- Normal 20 (11.2%) 1
- Mildly impaired 23 (36.5%) 4.37 (2.01–9.47)
- Moderately & severely impaired 9 (42.9%) 4.84 (1.59–14.78)
Comorbidities (n)d 4 (3–5) 1.59 (1.30–1.95)
Hemoglobin level
- $12g/dl 26 (16.8%) 1
- ,12g/dl 22 (22.9%) 1.06 (0.52–2.17)
Surgery
- Minor 4 (4.0%) 1
- Major 51 (29.3%) 7.43 (2.43–22.73)
Duration anesthesia (h)d 3 (2.3–5.0) 1.26 (1.08–1.47)
Blood loss during surgery (dl)d 2.0 (1.0–3.0) 1.33 (1.09–1.63)
aValid percentages were calculated when data were not available from all patients.
bBold = statistically significant.
cOverall significance.
dValues are median and first and third quartiles.
eDue to small numbers of patients living residential care/nursing home, the living situation could not be included in the logistic regression.
doi:10.1371/journal.pone.0086863.t004
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which 55 (40.7%) developed major complications. Other studies
investigating onco-geriatric surgical patients have found a high
incidence of post-operative morbidity as well [4,14]. The high
morbidity rates emphasize the importance of using pre-operative
screening tools to predict short-term post-operative outcome.
Moreover, these results point out the urgent need for pre-operative
optimization of a substantial percentage of onco-geriatric patients.
In a prospective study among patients $75 years old
undergoing major elective abdominal surgery, multivariable
analysis of the predictive value of a high TUG (.20.0 seconds)
for post-operative delirium showed a hazard ratio of 4.8. A total of
47.6% of patients with a high TUG suffered from post-operative
delirium, compared to only 18.5% of patients with a normal TUG
[26]. Robinson et al. found a 13 times higher risk of discharge to
an institutional care facility, i.e. nursing home or rehabilitation
center, for geriatric surgical patients with a high TUG ($15.0
seconds) [27]. In onco-geriatric patients undergoing chemother-
apy, a TUG over 20 seconds was found to be a risk factor of death
within six months [23]. These data show promising results
regarding the use of the TUG as a screening tool in several sets
of geriatric patients; to our knowledge this is the first study
investigating on the predictive value of the TUG in an onco-
geriatric surgical population.
The TUG is a well validated measure, which gives a reflection
of a person’s muscle strength, mobility and coordination. It is
reproducible and proved to be predictive of outcome in the setting
of the present large international cohort. However, the cut-off
point for the TUG varies greatly between studies, making it
difficult to compare outcome and stressing the importance of
reporting the used cut-off point. The wide range in cut-off points
could be depending on the characteristics of the studied
population [18]. Factors as age, whether subjects are hospitalized
or community-dwelling and off course the type of outcome
measure, are all of influence on the appropriate cut-off point of the
TUG score for specific cohorts. An established cut-off point cannot
be generalized to an entire population, the lack of a uniform cut-
off point for the TUG should therefore be accepted.
Data on ASA predicting the post-operative course have often
been studied in colorectal surgical patients, with conflicting results.
In a set of colorectal cancer surgical patients, patients with ASA$3
as a measure of comorbidity were at an increased risk of 30-day
mortality and experiencing surgical complications [13]. In
octogenarians undergoing colorectal cancer surgery, Tan et al.
found patients classified as ASA$3 being at increased risk of post-
operative morbidity [15] and Heriot et al. identified high ASA as a
risk factor of 30-day mortality. Patients classified as ASA3 had a
2.86 times higher risk of dying within the first 30 days after surgery
and in patients classified as ASA4 or ASA5 this risk increased to
6.08 [16]. In a similar population of elderly colorectal cancer
patients, however, high ASA was not identified as a risk factor of
post-operative complications [4]. This is in keeping with a broader
population of onco-geriatric surgical patients, where high ASA was
not found to be predictive of post-operative morbidity or mortality
[14].
The discrepancy between these results could partly be explained
by the interrater variability, which is a main disadvantage of the
use of ASA as a screening tool [31]. In the onco-geriatric surgical
population, where the majority of patients is classified as ASA2 or
ASA3 (table 2) [4], it is difficult to rely on ASA in order to make a
distinction between patients at risk of post-operative complications
and patients who are not. This suggests that ASA, which is the
combination of comorbidity and the clinician’s impression of a
patient’s functional status, might be not a valid measure to be a
decisive screening tool in the onco-geriatric surgical population.
The risk of 30-day mortality could not be predicted by TUG
nor ASA in the current cohort, which could be explained by lack
of power as calculation of the sample size was based on 30-day
morbidity. A limitation of the study was that PREOP did not focus
on long-term outcome. It is known that post-operative complica-
tions increase long-term mortality rates in elderly patients
undergoing major surgery [32], suggesting long-term mortality
rates as a better outcome measure than short-term mortality [33].
Nevertheless, it endorses post-operative morbidity as an appro-
priate endpoint for the geriatric population. The association
between post-operative morbidity and long-term mortality in the
onco-geriatric population remains to be confirmed.
The current results show that the TUG is a more useful
screening tool than ASA to identify those patients most at risk of
Table 5. Multivariable association of TUG and ASA with regard to major complications, prolonged LOS and.3 specialists involved
in patient care.
Major complication Stay .7 days .3 specialists involved
%a OR (95% CI)b %a OR (95% CI)c %a OR (95% CI)c
TUG p=0.03 p = 0.03 p = 0.003
- #20.0s (n = 237) 14.7% 1 49.8% 1 11.4% 1
- .20.0s (n = 42) 50.0% 3.43 (1.14–10.35) 70.0% 3.98 (1.12–14.10) 45.0% 5.20 (1.78–15.16)
ASA p =0.02d p = 0.11d p = 0.003d
- 1 (n = 26) 8.0% 1 69.2% 1 7.7% 1
- 2 (n = 131) 17.1% 5.91 (0.93–37.77) 45.8% 0.23 (0.05–0.99) 8.0% 2.67 (0.40–18.03)
- 3&4 (n = 120) 25.6% 12.77 (1.84–88.74) 55.9% 0.37 (0.08–1.68) 27.0% 12.55 (1.76–89.64)
TUG+ASA p =0.02 Chi2 NS p,0.001
- TUG#20+ ASA,3 (n = 142) 10.8% 1 47.2% 5.1% 1
- TUG.20+ ASA$3 (n = 26) 46.2% 5.22 (1.24–21.98) 66.7% 54.2% 25.31 (5.51–116.27)
aAbsolute risks; valid percentages were calculated when data were not available from all patients.
bAdjusted for center, minor/major surgery and nutritional status.
cAdjusted for center, gender, minor/major surgery and duration of anesthesia.
dOverall significance.
doi:10.1371/journal.pone.0086863.t005
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adverse outcome. Providing extra pre-operative care and pre-
habilitation to patients with a poor TUG performance may
improve the performance on the TUG and thus improve post-
operative outcome [34]. This is also emphasized by the ability of
TUG to predict the extra need of healthcare post-operatively,
shown by the prolonged LOS and the increased number of
specialists involved in patients with a high TUG. To optimize the
process of screening for elderly at risk of major post-operative
complications, more screening tools should be investigated and
compared to the results of TUG and ASA. A recent suggestion is
that a combination of screening tools, with different areas of
attention, could provide a better predictive value regarding the risk
of post-operative morbidity [35]. The final results of a comparison
between other instruments aimed at predicting the risk of post-
operative complications are awaited.
The PREOP-study is a large multicenter study, which is both a
strength and a limitation. Some centers included few patients and
patient selection as an explanation for these small number of
patients is plausible. We intercepted this by excluding centers who
included less than 10 patients. The possibly positive selection bias
would, however, certainly not make our findings less likely. The
great strength of our multicenter study is the broad generalizability
of our results to the onco-geriatric surgical population.
The present analysis suggests that the routine use of the TUG as
a screening tool in the onco-geriatric surgical population is of
clinical relevance as it is capable of selecting the majority of
patients at risk of post-operative complications. Efficiency entails
providing the extra pre-operative care to those who will benefit
most and within this scope, the TUG could be of great
importance.
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